Naprosyn

Known as: Naprosin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-2015
02419742015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Fever of unknown origin (FUO) remains a difficult diagnostic problem. The causes of FUO have changed over the years. Neoplastic… (More)
Is this relevant?
2005
2005
Currently, malignancies are more common than infections as a cause of fever of unknown origin (FUO) in adults. Many malignant… (More)
Is this relevant?
2002
2002
A 53-year-old Caucasian woman with long-standing, well controlled, severe rheumatoid arthritis, treated with methotrexate… (More)
Is this relevant?
1999
1999
The permeation of naproxen through excised human skin and isolated perfused rabbit ear skin has been determined. It was found… (More)
Is this relevant?
1996
1996
A double-blind, randomized study compared the efficacy and safety of a controlled-release naproxen sodium formulation (Naprelan… (More)
Is this relevant?
1994
1994
Osteoarthritis is the most common joint disease and the second highest ranking cause of disability in the US. Osteoarthritis… (More)
Is this relevant?
1990
1990
A double-blind, placebo-controlled trial was conducted to determine the effects of the nonsteroidal anti-inflammatory drug… (More)
Is this relevant?
1983
1983
 
Is this relevant?
1977
1977
The new antirheumatic agents, fenoprofen calcium, naproxen, and tolmetin sodium, are effective in the management of rheumatoid… (More)
Is this relevant?
1977
1977
A double-blind, cross-over comparison of Naprosyn (naproxen) 750 mg daily and Butacote (enteric-coated phenylbutazone) 300 mg… (More)
  • table 1
  • table 3
  • table 2
  • table 4
  • table 5
Is this relevant?